Tedizolid for the Management of Human Infections: In Vitro Characteristics

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

Ferraro, M. J. (2000) · Cited by 16,875 · see citing works

Clinical and Laboratory Standards Institute

Gressner, A. M., & Arndt, T. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,092 · see citing works

Linezolid resistance in a clinical isolate of Staphylococcus aureus

Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C. B., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,034 · see citing works

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K., & Quinn, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04376-2 · Cited by 542 · see citing works

Development of in vitro susceptibility testing criteria and quality control parameters

Novick, W. J. (1989) · Clinical Microbiology Newsletter · doi:10.1016/0196-4399(89)90068-8 · Cited by 409 · see citing works

Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome

Long, K. S., & Vester, B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05702-11 · Cited by 377 · see citing works

Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections

Prokocimer, P., Anda, C. S. D., Fang, E., Mehra, P., & Das, A. (2013) · JAMA · doi:10.1001/jama.2013.241 · Cited by 362 · see citing works

Identification of a Plasmid-Borne Chloramphenicol-Florfenicol Resistance Gene in Staphylococcus sciuri

Schwarz, Š., Werckenthin, C., & Kehrenberg, C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2530-2533.2000 · Cited by 342 · see citing works

Acquisition of a natural resistance gene renders a clinical strain of methicillin‐resistant<i>Staphylococcus aureus</i>resistant to the synthetic antibiotic linezolid

Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338 · see citing works

The emerging problem of linezolid-resistant Staphylococcus

Gu, B., Kelesidis, T., Tsiodras, S., Hindler, J. A., & Humphries, R. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks354 · Cited by 332 · see citing works

The Site of Action of Oxazolidinone Antibiotics in Living Bacteria and in Human Mitochondria

Leach, K. L., Swaney, S. M., Colca, J. R., McDonald, W. G., Blinn, J. R., Thomasco, L. M., Gadwood, R. C., Shinabarger, D. L., Xiong, L., & Mankin, A. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.005 · Cited by 278 · see citing works

The oxazolidinones: past, present, and future

Shaw, K. J., & Barbachyn, M. R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06330.x · Cited by 259 · see citing works

MRSA: the first half century

Moellering, R. C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr437 · Cited by 236 · see citing works

Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)

Locke, J. B., Hilgers, M. T., & Shaw, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00871-09 · Cited by 207 · see citing works

In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains

Shaw, K. J., Poppe, S. M., Schaadt, R. D., Brown‐Driver, V., Finn, J., Pillar, C. M., Shinabarger, D. L., & Zurenko, G. E. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00859-08 · Cited by 180 · see citing works

Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal Mutations

Locke, J. B., Finn, J., Hilgers, M. T., Morales, G., Rahawi, S., Kedar, G. C., Picazo, J. J., Im, W., Shaw, K. J., & Stein, J. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00663-10 · Cited by 153 · see citing works

Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent

Im, W. B., Choi, S. H., Park, J., Choi, S. H., Finn, J., & Yoon, S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.014 · Cited by 139 · see citing works

Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin

Locke, J. B., Hilgers, M. T., & Shaw, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01032-09 · Cited by 136 · see citing works

LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers)

Jones, R. N., Fritsche, T. R., Sader, H. S., & Ross, J. E. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.06.004 · Cited by 125 · see citing works

In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent

Schaadt, R. D., Sweeney, D., Shinabarger, D. L., & Zurenko, G. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00228-09 · Cited by 117 · see citing works

Transcriptional and Translational Control of the mlr Operon, Which Confers Resistance to Seven Classes of Protein Synthesis Inhibitors

Smith, L. K., & Mankin, A. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01583-07 · Cited by 116 · see citing works

Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers

Housman, S. T., Pope, J. S., Russomanno, J. H., Salerno, E., Shore, E. T., Kuti, J. L., & Nicolau, D. P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05354-11 · Cited by 105 · see citing works

Improving known classes of antibiotics: an optimistic approach for the future

Bush, K. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.06.003 · Cited by 100 · see citing works

Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci

Livermore, D. M., Mushtaq, S., Warner, M., & Woodford, N. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp002 · Cited by 89 · see citing works

In Vitro Activity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections

Prokocimer, P., Bien, P. A., DeAnda, C., Pillar, C. M., & Bartizal, K. F. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00458-12 · Cited by 88 · see citing works

Comparative In Vitro Antimicrobial Activities of Torezolid (TR-700), the Active Moiety of a New Oxazolidinone, Torezolid Phosphate (TR-701), Determination of Tentative Disk Diffusion Interpretive Criteria, and Quality Control Ranges

Brown, S. D., & Traczewski, M. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01569-09 · Cited by 84 · see citing works

Elevated Linezolid Resistance in Clinical cfr -Positive Staphylococcus aureus Isolates Is Associated with Co-Occurring Mutations in Ribosomal Protein L3

Locke, J. B., Morales, G., Hilgers, M. T., Kedar, G. C., Rahawi, S., Picazo, J. J., Shaw, K. J., & Stein, J. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-10 · Cited by 77 · see citing works

Tedizolid (TR-701): a new oxazolidinone with enhanced potency

Kanafani, Z. A., & Corey, G. R. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.660250 · Cited by 68 · see citing works

Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?

Gould, I. M., Cauda, R., Esposito, S., Gudiol, F., Mazzei, T., & Garau, J. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.10.030 · Cited by 65 · see citing works

Genetic Environment and Stability of cfr in Methicillin-Resistant Staphylococcus aureus CM05

Locke, J. B., Rahawi, S., LaMarre, J. M., Mankin, A. S., & Shaw, K. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05420-11 · Cited by 65 · see citing works

Low Fitness Cost of the Multidrug Resistance Gene cfr

LaMarre, J. M., Locke, J. B., Shaw, K. J., & Mankin, A. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00153-11 · Cited by 64 · see citing works

Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines

Lemaire, S., Françoise Van Bambeke, A., Appelbaum, P. C., & Tulkens, P. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp267 · Cited by 60 · see citing works

LEADER Surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers)

Flamm, R. K., Farrell, D. J., Mendes, R. E., Ross, J. E., Sader, H. S., & Jones, R. N. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.05.012 · Cited by 51 · see citing works

Distinguishing On-Target versus Off-Target Activity in Early Antibacterial Drug Discovery Using a Macromolecular Synthesis Assay

Cunningham, M. L., Kwan, B. P., Nelson, K. J., Bensen, D. C., & Shaw, K. J. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113487208 · Cited by 40 · see citing works

TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens

Jones, R., Moet, G., Sader, H. S., Mendes, R. E., & Castanheira, M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp021 · Cited by 39 · see citing works

The Chemistry of Peptidyltransferase Center-Targeted Antibiotics: Enzymatic Resistance and Approaches to Countering Resistance

McCusker, K. P., & Fujimori, D. G. (2011) · ACS Chemical Biology · doi:10.1021/cb200418f · Cited by 32 · see citing works

Comparative In Vitro Activities of Torezolid (DA-7157) against Clinical Isolates of Aerobic and Anaerobic Bacteria in South Korea

Yum, J. H., Choi, S. H., Yong, D., Chong, Y., Im, W. B., Rhee, D., & Lee, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00728-10 · Cited by 30 · see citing works

Comparative Activities of TR-700 (Torezolid) against Staphylococcal Blood Isolates Collected in Spain

Betriú, C., Morales, G., Rodríguez-Avial, I., Culebras, E., Gómez, M., López, F., & Picazo, J. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01653-09 · Cited by 24 · see citing works

Activity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1 macrophages

Cabrera, L. V., Espinoza-González, N. A., Welsh, O., Ocampo‐Candiani, J., & Castro‐Garza, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp314 · Cited by 15 · see citing works

Resistance to linezolid in a methicillin-susceptible Staphylococcus aureus clinical isolate without previous exposure to oxazolidinones

Quiles-Melero, I., García-Perea, A., de Pablos, M., Gómez-Gil, R., & Mingorance, J. (2012) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2012.03.001 · Cited by 12 · see citing works

Mechanisms of Antibiotic Resistance

Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782 · see citing works

Antibiotic resistance in Staphylococcus aureus. Current status and future prospects

Foster, T. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux007 · Cited by 883 · see citing works

A novel gene, optrA , that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin

Wang, Y., Lv, Y., Cai, J., Schwarz, Š., Cui, L., Hu, Z., Zhang, R., Li, J., Zhao, Q., He, T., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv116 · Cited by 546 · see citing works

Antibiotic Resistance and the MRSA Problem

Vestergaard, M. R., Frees, D., & Ingmer, H. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0057-2018 · Cited by 515 · see citing works

Mechanisms of antibiotic resistance

Munita, J. M., & Arias, C. A. (2016) · Virulence Mechanisms of Bacterial Pathogens · doi:10.1128/9781555819286.ch17 · Cited by 421 · see citing works

Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature

Bender, J. K., Cattoir, V., Hegstad, K., Sadowy, E., Coque, T. M., Westh, H., Hammerum, A. M., Schaffer, K., Burns, K., Murchan, S., et al. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.10.002 · Cited by 281 · see citing works

What is an “ideal” antibiotic? Discovery challenges and path forward

Singh, S. B., Young, K., & Silver, L. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.003 · Cited by 201 · see citing works

Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens

Zhanel, G. G., Love, R., Adam, H. J., Golden, A., Zelenitsky, S. A., Schweizer, F., Gorityala, B. K., Lagacé-Wiens, P. R. S., Rubinstein, E., Walkty, A. J., et al. (2015) · Drugs · doi:10.1007/s40265-015-0352-7 · Cited by 186 · see citing works

Linezolid: a promising option in the treatment of Gram-positives

Bialvaei, A. Z., Rahbar, M., Yousefi, M., Asgharzadeh, M., & Kafil, H. S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw450 · Cited by 171 · see citing works

Genetic environment of the transferable oxazolidinone/phenicol resistance gene optrA in Enterococcus faecalis isolates of human and animal origin

He, T., Shen, Y., Schwarz, Š., Cai, J., Lv, Y., Li, J., Feßler, A. T., Zhang, R., Wu, C., Shen, J., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw016 · Cited by 155 · see citing works

Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections

Shorr, A. F., Lodise, T. P., Corey, G. R., Anda, C. S. D., Fang, E., Das, A., & Prokocimer, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03688-14 · Cited by 139 · see citing works

Evolving Resistance Among Gram-positive Pathogens

Munita, J. M., Bayer, A. S., & Arias, C. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ523 · Cited by 134 · see citing works

A metal–metalloporphyrin framework based on an octatopic porphyrin ligand for chemical fixation of CO 2 with aziridines

Wang, X., Gao, W., Niu, Z., Wojtas, Ł., Perman, J. A., Chen, Y., Li, Z., Aguila, B., & Ma, S. (2017) · Chemical Communications · doi:10.1039/c7cc08844b · Cited by 122 · see citing works

Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic

Burdette, S. D., & Trotman, R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ501 · Cited by 110 · see citing works

Enterococcal isolates carrying the novel oxazolidinone resistance gene optrA from hospitals in Zhejiang, Guangdong, and Henan, China, 2010–2014

Cai, J., Wang, Y., Schwarz, Š., Lv, H., Li, Y.-J., Liao, K., Yu, S. N., Zhao, K., Gu, D., Wang, X., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.08.007 · Cited by 98 · see citing works

Prevalence and Abundance of Florfenicol and Linezolid Resistance Genes in Soils Adjacent to Swine Feedlots

Zhao, Q., Wang, Y., Wang, S., Wang, Z., Du, X., Jiang, H., Xia, X., Shen, Z., Ding, S., Wu, C., et al. (2016) · Scientific Reports · doi:10.1038/srep32192 · Cited by 97 · see citing works

Current and future treatment options for community-associated MRSA infection

Khan, A. H., Wilson, B., & Gould, I. M. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1442826 · Cited by 92 · see citing works

In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria

Brown‐Elliott, B. A., & Wallace, R. J. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00274-17 · Cited by 90 · see citing works

Tedizolid Phosphate: a Next-Generation Oxazolidinone

Rybak, J. M., & Roberts, K. D. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0060-3 · Cited by 83 · see citing works

Absorption, Distribution, Metabolism, and Excretion of the Novel Antibacterial Prodrug Tedizolid Phosphate

Ong, V. S., Flanagan, S. D., Fang, E., Dreskin, H. J., Locke, J. B., Bartizal, K. F., & Prokocimer, P. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056697 · Cited by 80 · see citing works

Mechanisms of antimicrobial resistance among hospital-associated pathogens

Khan, A., Miller, W. R., & Arias, C. A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1456919 · Cited by 77 · see citing works

Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond

Holmes, N. E., Tong, S. Y. C., Davis, J. S., & van Hal, S. J. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1397040 · Cited by 76 · see citing works

Nickel based metal-organic framework as catalyst for chemical fixation of CO2 in oxazolidinone synthesis

Helal, A., Fettouhi, M., Arafat, M. E., Khan, M. Y., & Sanhoob, M. A. (2021) · Journal of CO2 Utilization · doi:10.1016/j.jcou.2021.101603 · Cited by 64 · see citing works

Binding and Action of Amino Acid Analogs of Chloramphenicol upon the Bacterial Ribosome

Tereshchenkov, A. G., Dobosz-Bartoszek, M., Osterman, I. А., Marks, J., Sergeeva, V. A., Kasatsky, P. S., Komarova, E. S., Ставрианиди, А. Н., Родин, И. А., Konevega, A. L., et al. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.016 · Cited by 62 · see citing works

Defect-engineering a metal–organic framework for CO 2 fixation in the synthesis of bioactive oxazolidinones

Helal, A., Cordova, K. E., Arafat, M. E., Usman, M., & Yamani, Z. H. (2020) · Inorganic Chemistry Frontiers · doi:10.1039/d0qi00496k · Cited by 61 · see citing works

Antibiotic Resistance and the MRSA Problem

Vestergaard, M. R., Frees, D., & Ingmer, H. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch47 · Cited by 52 · see citing works

Whatʼs new in the treatment of serious MRSA infection?

Holmes, N. E., & Howden, B. P. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000101 · Cited by 45 · see citing works

In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia

Chen, K.-H., Huang, Y., Liao, C., Sheng, W.-H., & Hsueh, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00390-15 · Cited by 42 · see citing works

Analysis of combined resistance to oxazolidinones and phenicols among bacteria from dogs fed with raw meat/vegetables and the respective food items

Wu, Y., Fan, R., Wang, Y., Lei, L., Feßler, A. T., Wang, Z., Wu, C., Schwarz, Š., & Wang, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-51918-y · Cited by 40 · see citing works

Oxazolidinone antimicrobials: a patent review (2012-2015)

Phillips, O. A., & Sharaf, L. H. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1168807 · Cited by 38 · see citing works

Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014

Pfaller, M. A., Flamm, R. K., Jones, R. N., Farrell, D. J., & Mendes, R. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00881-16 · Cited by 38 · see citing works

Simultaneous determination of tedizolid and linezolid in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study

Yu, H., Pan, C., Xie, Q., Zheng, Y., Hu, Y.-Z., & Lin, Y. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.12.056 · Cited by 37 · see citing works

Activity of Tedizolid in Methicillin-Resistant Staphylococcus epidermidis Experimental Foreign Body-Associated Osteomyelitis

Park, K. H., Greenwood‐Quaintance, K. E., Schuetz, A. N., Mandrekar, J. N., & Patel, R. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01644-16 · Cited by 32 · see citing works

Transferable Resistance Gene optrA in Enterococcus faecalis from Swine in Brazil

de Almeida, L. M., Lebreton, F., Gaca, A. O., Bispo, P. J. M., Saavedra, J. T., Calumby, R. J. N., Grillo, L. A. M., do Nascimento, T. G., Filsner, P. H. D. L. N., Moreno, A. M., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00142-20 · Cited by 32 · see citing works

New antibiotics against gram-positives: present and future indications

Morata, L., Mensa, J., & Soriano, À. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.07.004 · Cited by 31 · see citing works

Effect of tedizolid on clinical Enterococcus isolates: in vitro activity, distribution of virulence factor, resistance genes and multilocus sequence typing

Bai, B., Hu, K., Li, H., Yao, W., Li, D., Chen, Z., Cheng, H., Zheng, J., Pan, W., Deng, M., et al. (2017) · FEMS Microbiology Letters · doi:10.1093/femsle/fnx284 · Cited by 31 · see citing works

Current status and recent trends in innovative tactics and the One Health approach to address the challenge of methicillin-resistant Staphylococcus aureus infections: a comprehensive review

Hajhamed, N. M., Mohamed, N. S., Abdalla, A. E., Ebrahim, R. M. A., Mohammed, S. I., Bakheit, A. M., Azhary, A., Ahmed, A. E., Abdelbagi, A., Ali, M. S. E., et al. (2025) · Discover Medicine · doi:10.1007/s44337-025-00300-1 · Cited by 30 · see citing works

Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia

Montravers, P., Harpan, A., & Guivarch, E. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0293-x · Cited by 30 · see citing works

In Vitro Susceptibility Testing of Tedizolid against Isolates of Nocardia

Brown‐Elliott, B. A., & Wallace, R. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01537-17 · Cited by 30 · see citing works

Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone

Zurenko, G. E., Bien, P. A., Bensaci, M., Patel, H. N., & Thorne, G. M. (2014) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-014-0046-0 · Cited by 29 · see citing works

Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents

Bradley, J. S., Flanagan, S. D., Arrieta, A. C., Jacobs, R. F., Capparelli, E. V., & Prokocimer, P. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001096 · Cited by 27 · see citing works

Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections

McBride, D., Krekel, T., Hsueh, K., & Durkin, M. J. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1290080 · Cited by 27 · see citing works

Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection Models

Abdelraouf, K., & Nicolau, D. P. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01957-16 · Cited by 26 · see citing works

Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates

Klupp, E.-M., Both, A., Campos, C. E. B., Büttner, H., König, C., Christopeit, M., Christner, M., Aepfelbacher, M., & Rohde, H. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2747-0 · Cited by 26 · see citing works

Methicillin-resistantStaphylococcus aureuspneumonia in adults

Woods, C. J., & Colice, G. (2014) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.940323 · Cited by 25 · see citing works

Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis

Park, K., Greenwood‐Quaintance, K. E., Mandrekar, J. N., & Patel, R. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01248-16 · Cited by 25 · see citing works

Recent advances in the rational design and optimization of antibacterial agents

Jones, J. A., Virga, K. G., Gumina, G., & Hevener, K. E. (2016) · MedChemComm · doi:10.1039/c6md00232c · Cited by 24 · see citing works

Antimicrobial and immunomodulatory effects of tedizolid against methicillin-resistant Staphylococcus aureus in a murine model of hematogenous pulmonary infection

Kaku, N., Morinaga, Y., Takeda, K., Kosai, K., Uno, N., Hasegawa, H., Miyazaki, T., Izumikawa, K., Mukae, H., & Yanagihara, K. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.05.010 · Cited by 23 · see citing works

Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections

Ferrández, O., Urbina, O., & Grau, S. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s84667 · Cited by 23 · see citing works

Two Stable Heterometal‐MOFs as Highly Efficient and Recyclable Catalysts in the CO2 Coupling Reaction with Aziridines

Kang, X., Yao, L., Jiao, Z., & Zhao, B. (2019) · Chemistry - An Asian Journal · doi:10.1002/asia.201900712 · Cited by 23 · see citing works

Activity of tedizolid against gram-positive clinical isolates causing infections in Europe and surrounding areas (2014–2015)

Pfaller, M. A., Sader, H. S., Shortridge, D., Castanheira, M., Flamm, R. K., & Mendes, R. E. (2019) · Journal of Chemotherapy · doi:10.1080/1120009x.2019.1609740 · Cited by 21 · see citing works

Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now?

Edwards, B., Andini, R., Esposito, S., Grossi, P., Lew, D., Mazzei, T., Novelli, A., Soriano, À., & Gould, I. M. (2014) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2014.03.009 · Cited by 21 · see citing works

In vitro antimicrobial activity of the novel oxazolidinone tedizolid and comparator agents against Staphylococcus aureus and linezolid-resistant Gram-positive pathogens: a multicentre study in China

Chen, H., Yang, Q., Zhang, R., He, W., Ma, X., Zhang, J., Xia, F., Zhao, F., Cao, J., Liu, Y., et al. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.05.007 · Cited by 21 · see citing works

Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patients

Roch, M., Varela, M. C., Taglialegna, A., & Rosato, A. E. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz418 · Cited by 21 · see citing works

Comparative pharmacokinetics of tedizolid in rat plasma and cerebrospinal fluid

Gu, L., Ma, M., Zhang, Y., Zhang, L., Sheng, Z., Huang, M., Zhang, M., Xin, Y., Zheng, G., & Chen, S. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.104420 · Cited by 20 · see citing works

Alternatives to Fight Vancomycin-Resistant Staphylococci and Enterococci

Baëtz, B., Boudrioua, A., Hartke, A., & Giraud, C. (2021) · Antibiotics · doi:10.3390/antibiotics10091116 · Cited by 20 · see citing works

Real-World Use of Tedizolid Phosphate for 28 Days or More: A Case Series Describing Tolerability and Clinical Success

Morrisette, T., Molina, K. C., Silva, B. D., Mueller, S. W., Damioli, L. E., Kršák, M., Miller, M. A., & Fish, D. N. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac028 · Cited by 18 · see citing works

In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid

Vanegas, J. M., Ocampo, A. M., Montoya-Urrego, D., & Jiménez, J. N. (2017) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2017.03.010 · Cited by 18 · see citing works

In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016

Karlowsky, J. A., Hackel, M., Bouchillon, S. K., Alder, J. D., & Sahm, D. F. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.07.001 · Cited by 18 · see citing works

Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin-sensitive and methicillin-resistant Staphylococcus aureus

Katahira, E. J., Davidson, S. M., Stevens, D. L., & Bolz, D. D. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000905 · Cited by 19 · see citing works

New agents approved for treatment of acute staphylococcal skin infections

Tatarkiewicz, J., Staniszewska, A., & Bujalska‐Zadrożny, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.59838 · Cited by 17 · see citing works

A highly sensitive and efficient UPLC‐MS/MS assay for rapid analysis of tedizolid (a novel oxazolidinone antibiotic) in plasma sample

Iqbal, M. (2016) · Biomedical Chromatography · doi:10.1002/bmc.3749 · Cited by 17 · see citing works

Tedizolid (torezolid) for the treatment of complicated skin and skin structure infections

Carena, A. A., & Stryjewski, M. E. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1774362 · Cited by 16 · see citing works

Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections

Hall, R. G., & Michaels, H. N. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s56691 · Cited by 15 · see citing works

Staph wars: the antibiotic pipeline strikes back

Douglas, E. J. A., & Laabei, M. (2023) · Microbiology · doi:10.1099/mic.0.001387 · Cited by 15 · see citing works

Tedizolid activity against a multicentre worldwide collection of Staphylococcus aureus and Streptococcus pneumoniae recovered from patients with pneumonia (2017–2019)

Carvalhaes, C. G., Sader, H. S., Rhomberg, P. R., & Mendes, R. E. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.04.014 · Cited by 14 · see citing works

Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA and Europe (2014–17)

Carvalhaes, C. G., Sader, H. S., Flamm, R. K., & Mendes, R. E. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz120 · Cited by 13 · see citing works

UPLC-MS/MS assay of Tedizolid in rabbit aqueous humor: Application to ocular pharmacokinetic study

Kalam, M. A., Iqbal, M., Alshememry, A. K., Alkholief, M. A., & Alshamsan, A. (2021) · Journal of Chromatography B · doi:10.1016/j.jchromb.2021.122621 · Cited by 13 · see citing works

In Vitro Activity of Tedizolid in Comparison with Other Oral and Intravenous Agents Against a Collection of Community-Acquired Methicillin-Resistant Staphylococcus aureus (2014–2015) in the United States

Pfaller, M. A., Sader, H. S., Rhomberg, P. R., Flamm, R. K., & Mendes, R. E. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0410 · Cited by 12 · see citing works

A new fluorescence method for specific determination of tedizolid in real human plasma: Based on twisted intramolecular charge transfer (TICT) blocking

Mohamed, A. A., Derayea, S. M., & Omar, M. A. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.116593 · Cited by 12 · see citing works

Current role of oxazolidinones and lipoglycopeptides in skin and soft tissue infections

Righi, E., Carnelutti, A., & Bassetti, M. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000529 · Cited by 10 · see citing works

High prevalence and plasmidome diversity of optrA-positive enterococci in a Shenzhen community, China

Fu, Y., Deng, Z., Shen, Y., Wei, W., Xiang, Q., Liu, Z., Hanf, K., Huang, S., Lv, Z., Cao, T., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1505107 · Cited by 9 · see citing works

Chemotherapeutic Strategies for Combating Staphylococcus aureus Infections

Sharma, N., Chhillar, A. K., Dahiya, S., Punia, A., Choudhary, P., Gulia, P., Behl, A., & Dangi, M. (2021) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666210402150325 · Cited by 9 · see citing works

Multiple Bacterial Strategies to Survive Antibiotic Pressure: A ReviewPreprint

Zakaria, N. F. S., Yahya, M. F. Z. R., & Jamil, N. M. (2023) · Preprints.org · doi:10.20944/preprints202304.0591.v1 · Cited by 8 · see citing works

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections

Molina, K. C., & Huang, V. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0553-6 · Cited by 8 · see citing works

Validation of a Commercial Dry-Form Broth Microdilution Device (Sensititre) for Testing Tedizolid, a New Oxazolidinone

Jones, R. N., Holliday, N. M., & Rhomberg, P. R. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02769-14 · Cited by 8 · see citing works

Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA, Europe, Latin America, and the Asia-Pacific region (2015-2019)

Pfaller, M. A., Mendes, R. E., Streit, J. M., & Carvalhaes, C. G. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2022.115804 · Cited by 8 · see citing works

Kinetic study of the formation reaction of N-chloro-2-oxazolidinone

Pastoriza, C., Antelo, J. M., Amoedo, F. A., & Parajo, M. (2015) · Journal of Physical Organic Chemistry · doi:10.1002/poc.3458 · Cited by 7 · see citing works

A strategy to re-sensitise drug-resistant Gram-positive bacteria to oxazolidinone-class antibiotics

Zhang, Q., Yang, Y., Yang, Y., Shang, J., Su, S., Gao, P., Li, X., Liu, Z., Kao, R. Y. T., Ko, B. C. B., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105914 · Cited by 6 · see citing works

In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States

Farrell, D. J., Mendes, R. E., & Bensaci, M. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.08.006 · Cited by 6 · see citing works

Incidence of serotonin syndrome in patients receiving tedizolid and concomitant serotonergic agents

Fang, Y., Clarke, L. G., Smith, B. J., & Shah, S. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00870-24 · Cited by 5 · see citing works

Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections

Lin, S., Huang, C., Ko, W., Chen, Y., & Hsueh, P. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1122756 · Cited by 5 · see citing works

Current Status and Future Perspectives of Antibiotic Therapy for MRSA InfectionsPreprint

Hajhamed, N. M., Abdalla, A. E., Mohammed, S. I., Ahmed, A. E., Bakheit, A. M., Abdelbagi, A., Ali, M. S. E., Omer, R. A., Siddig, E. E., Ahmed, A., et al. (2023) · Preprints.org · doi:10.20944/preprints202304.0180.v1 · Cited by 4 · see citing works

Antibacterial Agents

Sauberan, J. B., Neely, M. N., & Bradley, J. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00292-5 · Cited by 3 · see citing works

Determination of Tedizolid susceptibility interpretive criteria for gram-positive pathogens according to clinical and laboratory standards institute guidelines

Bensaci, M., Flanagan, S. D., & Sandison, T. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.10.023 · Cited by 3 · see citing works

Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options)

Payne, K. D., Das, A., Ndiulor, M., & Hall, R. G. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1411800 · Cited by 3 · see citing works

Tedizolid versus linezolid activity against Staphylococcus aureus clinical isolates

Elnagar, R., Mahmoud, R., & El-Kady, R. A. E.-H. (2022) · The Egyptian Journal of Medical Microbiology · doi:10.21608/ejmm.2022.262687 · Cited by 2 · see citing works

Actividad comparativa de tedizolid frente a Staphylococcus coagulasa negativos resistentes a linezolid y Staphylococcus aureus resistentes a meticilina

Pérez-Parra, S., Peña-Monje, A., Recio-López, J. L., & García-García, F. (2016) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2016.08.004 · Cited by 2 · see citing works

Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options)

Hall, R. G., Thatcher, M. D., Wei, W., Varghese, S., Varughese, L., Ndiulor, M., & Payne, K. D. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1300527 · Cited by 2 · see citing works

A mean-field approach for modeling the propagation of perturbations in biochemical reaction networks

Przedborski, M., Sharon, D. M., Chan, S. M., & Kohandel, M. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105919 · Cited by 2 · see citing works

Comparative activity of tedizolid against clinical isolates of linezolid-resistant coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus

Pérez-Parra, S., Peña-Monje, A., Recio-López, J. L., & García-García, F. (2017) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2017.03.012 · Cited by 1 · see citing works

In Vitro Activity of Tedizolid against Gram-Positive Cocci Isolates from Patients Hospitalized with Pneumonia in the United States and Europe, 2014-2016

Bensaci, M., Tan, C., Ma, P., & Mendes, R. E. (2018) · Journal of Infectious Diseases and Treatment · doi:10.21767/2472-1093.100040 · Cited by 1 · see citing works

The Super Bug Staph: Vancomycin and Alternative Therapy

Elnour, A. A. (2016) · SOJ Pharmacy & Pharmaceutical Sciences · doi:10.15226/2374-6866/3/1/00134

Mechanisms of Action of Antibacterial Agents

Buensalido, J. A. L., DeMarco, C. E., & Lerner, S. (2015) · CRC Press eBooks · doi:10.1201/b17871-13

Caracterização fenotípica e genotípica de Staphylococcus aureus resistentes à meticilina (MRSA) isolados de sítios de infecção de pacientes em um hospital de São Carlos

Okado, J. B. (2018) · doi:10.11606/t.76.2018.tde-29012018-101447

Caracterização molecular de isolados ambientais de Enterococcus faecalis e Enterococcus faecium

dos Santos, L. D. R. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2021.tde-29092021-084059

Tedizolid

Fernando, S. A., Shahabi-Sirjani, A., & Gottlieb, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00206-1

Oxazolidinone

Hussain, E. A., Ghani, A., & Sadiq, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85386-6.00007-x

Antibacterial Therapeutic Agents

Stimes, G. T., & Palazzi, D. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00252-1

Emergence de la résistance au linézolide chez les staphylocoques

Rouard, C. (2018) · doi:10.70675/351eca54zf02bz4f43z8d77zf0279402be4f

Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens

Zhanel, G. G., Love, R., Adam, H. J., Golden, A., Zelenitsky, S. A., Schweizer, F., Gorityala, B. K., Lagacé-Wiens, P. R. S., Rubinstein, E., Walkty, A. J., et al. (2015) · Drugs · doi:10.1007/s40265-015-0352-7 · Cited by 186 · see citing works

Results of the Surveillance of Tedizolid Activity and Resistance Program: in vitro susceptibility of Gram-positive pathogens collected in 2011 and 2012 from the United States and Europe

Sahm, D. F., Deane, J., Bien, P. A., Locke, J. B., Zuill, D. E., Shaw, K. J., & Bartizal, K. F. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.08.011 · Cited by 73 · see citing works

New and old oxazolidinones: tedizolid vs. linezolid

Dekhnich, A. V., & Хачатрян, Н. Н. (2017) · DOAJ (DOAJ: Directory of Open Access Journals)

Tedizolid

Fernando, S. A., Shahabi-Sirjani, A., & Gottlieb, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00206-1

Early Experience with Tedizolid: Clinical Efficacy, Pharmacodynamics, and Resistance

Rybak, J. M., Marx, K. R., & Martin, C. A. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1491 · Cited by 52 · see citing works